How we test
How we test for disease
Prostate Cancer Screening
The lives of almost all the 10,000 men who die of prostate cancer each year in the UK could potentially be saved if they were diagnosed and treated early enough; but screening is controversial. Prostate cancer detection begins with a PSA blood test. High PSA levels raise suspicions of cancer, but cannot provide a reliable diagnosis because PSA alone may give a false positive or false negative result. So further investigation is necessary.
This is traditionally done by taking tiny samples of prostate tissue (biopsies), usually via a needle through the rectum. The procedure is uncomfortable and carries a risk of serious infection and other complications.
The Advanced Screening Centre difference: Multiparametric 3T MRI
New, high-definition MRI technology provides far superior images of the prostate, enabling the radiologist to identify the presence and location of a prostate tumour.
This means we can use it (with PSA) either as a screening tool for those at risk, or before proceeding to biopsy if PSA levels are raised. Men whose MRI is clear may avoid unnecessary biopsies and simply continue with regular PSA monitoring.
What happens if we detect signs of prostate cancer?
The issues are complex and you must seek expert advice. As a client of The Advanced Screening Centre you have access to the UK’s leading specialists for an explanation of your options or referral elsewhere, as you wish.